What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Immune system
Immunology, Autoantibody, Systemic lupus erythematosus, Anti-nuclear antibody and Autoimmunity are his primary areas of study.
His Immunology research is multidisciplinary, incorporating perspectives in Internal medicine and microRNA.
His Autoantibody study incorporates themes from Immunoglobulin G and Dermatomyositis.
His research in Systemic lupus erythematosus intersects with topics in Lupus erythematosus, Lupus nephritis, Glomerulonephritis and Interferon type I.
His study in Anti-nuclear antibody is interdisciplinary in nature, drawing from both Indirect immunofluorescence, Crithidia luciliae, Bioinformatics, Scleroderma and Disease.
His Autoimmunity research is multidisciplinary, incorporating perspectives in Adjuvant and Virology.
His most cited work include:
- Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients (541 citations)
- Disruption of GW bodies impairs mammalian RNA interference (418 citations)
- miR-146a Is Critical for Endotoxin-induced Tolerance IMPLICATION IN INNATE IMMUNITY (316 citations)
What are the main themes of his work throughout his whole career to date?
Minoru Satoh mainly investigates Immunology, Autoantibody, Antibody, Molecular biology and Internal medicine.
His research on Immunology often connects related areas such as Systemic lupus erythematosus.
Anti-nuclear antibody is the focus of his Autoantibody research.
The Antibody study combines topics in areas such as Virology and Pathology.
His studies deal with areas such as Recombinant DNA, Immunoprecipitation, RNA, Ribonucleoprotein and RNA silencing as well as Molecular biology.
He interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
He most often published in these fields:
- Immunology (65.22%)
- Autoantibody (58.33%)
- Antibody (30.80%)
What were the highlights of his more recent work (between 2015-2021)?
- Autoantibody (58.33%)
- Immunology (65.22%)
- Antibody (30.80%)
In recent papers he was focusing on the following fields of study:
Minoru Satoh focuses on Autoantibody, Immunology, Antibody, Dermatomyositis and Internal medicine.
Minoru Satoh works in the field of Autoantibody, namely Anti-nuclear antibody.
His Immunology research is multidisciplinary, incorporating elements of Disease and Rheumatology.
Minoru Satoh has included themes like Ribonucleoprotein, Clinical significance, Antigen and Blot in his Antibody study.
His Dermatomyositis research incorporates themes from Polymyositis, Anti-SSA/Ro autoantibodies, IIf and Interstitial lung disease.
His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine.
Between 2015 and 2021, his most popular works were:
- A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. (135 citations)
- Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective (81 citations)
- International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results (67 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Immune system
Minoru Satoh spends much of his time researching Autoantibody, Immunology, Dermatomyositis, Polymyositis and Anti-nuclear antibody.
His Autoantibody study is focused on Antibody in general.
As part of his studies on Immunology, Minoru Satoh frequently links adjacent subjects like Petechial rash.
His study looks at the relationship between Dermatomyositis and topics such as Interstitial lung disease, which overlap with Myopathy, Inflammatory myopathy, Spleen and Connective tissue disease.
His biological study spans a wide range of topics, including Ribonucleoprotein, Prospective cohort study, Antisynthetase syndrome and Myositis.
His work in Anti-nuclear antibody covers topics such as Indirect immunofluorescence which are related to areas like Clinical significance, DNA Topoisomerase I and Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
